Inhalation Tuesday, April 24, 2018
Skip Navigation LinksHome) Webinar 2016-09/27 Challenges Associated
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.

Challenges Associated with Delivering Inhaled Medications to the Older Patient: Considerations for Developers and Manufacturers When Designing Inhaled Devices

Tuesday, September 27, 2016

Time:  12:00 PM (Noon) – 1:30 PM ET

Presenter:  Dr. Jolyon Mitchell

Moderator:  Dr. David Cipolla

Webinar Cost:  FREE

Webinar Details:  With the aging of the global population, it is expected that pharmaceutical manufacturers will begin developing new inhaled medical devices with a focus on the special needs of the older patient group.

This webinar will focus on all the major forms of inhaled products and discuss factors that developers and manufacturers should consider when developing new inhalers for these patients. These can include changes in lung function due to aging, presence of respiratory diseases and comorbidities; limitations in manual dexterity and strength, vision and cognition; and possible lack of family support.

Another key consideration is human factors analysis and design of those studies. Additional webinar material will discuss construction of patient instructions for use and education of prescribing clinicians and pharmacists.

Presenter Information:  Dr. Jolyon Mitchell, PhD, FRSC (UK), CChem. CSci, is the CEO of Jolyon Mitchell Inhaler Consulting Services Inc., specializing in the laboratory evaluation of all types of orally inhaled products (OIPs). Formerly Scientific Director of Trudell Medical International, he is a Scientific Adviser to IPAC-RS and has an active role in EPAG. He played a major part in standards development for ISO 20072:2009, ISO 27427:2010, and CAN/CSA Z264.1-02:2002 (rev. 2008). He was appointed to the 2010-2015 and 2015-2020 sessions of the USP Expert Committee: General Chapters – Dosage Forms, and currently co-chairs the Aerosols subcommittee. He is an adjunct professor at the University of Western Ontario and an affiliate professor at University of Hawaii. He is on the Editorial Advisory Board for Inhalation, has published more than 400 articles and contributed to five books relating to aerosol technology and inhaler products in particular.

Moderator Information:  Dr. David Cipolla is the Vice President of Preclinical R&D and Pharmaceutical Sciences at Aradigm Corporation. His focus is on development of formulation and drug delivery technologies to support pharmaceutical product development. He also leads the company’s intellectual property efforts. David has served as chair of IPAC-RS and chair of the ISAM Regulatory Affairs Working Group. He has co-organized a variety of conferences including the 2009 ISAM Conference. In addition, he serves on the editorial boards of the Journal of Aerosol Medicine and Pulmonary Drug Delivery, Inhalation and Pharmaceutical Patent Analyst.

Can’t attend?  If you register for a webinar but can't attend the live event, an archived version will be accessible online for 30 days once it concludes. This allows you to view the entire webinar presentation and Q&A session at a time most convenient to your schedule.

PDH Information:  If you are working on a certification or licensing program that allows Professional Development Hours, CSC Publishing Inc. will (upon request) provide a Certificate of Participation for our educational webinars put on by Inhalation. One certificate per registered participant will be sent if the webinar is viewed. You should check with your employer or local agency to confirm their specific PDH requirements. In many cases, our educational webinars will contribute toward these hours.

Visit our sponsors:

      Copyright 2018, CSC Publishing Inc. ALL Rights Reserved * Privacy policy